Loading Bayer Cropscience…
| ₹ Cr | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Revenue | 1,835 | 1,101 | 1,106 | 1,553 | 1,915 |
| Operating profit | 318 | 165 | 102 | 191 | 321 |
| Operating margin | 17.3% | 15.0% | 9.2% | 12.3% | 16.8% |
| Net profit | 322 | 162 | 96 | 153 | 279 |
| Net margin | 17.5% | 14.7% | 8.7% | 9.8% | 14.6% |
| EPS (₹) | 71.56 | 36.07 | 21.29 | 33.98 | 62.01 |
Quarters are labelled by period end.
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | 5,498 | 5,314 | 4,892 | 4,945 |
| Operating profit | 784 | 609 | 909 | 860 |
| Operating margin | 14.3% | 11.5% | 18.6% | 17.4% |
| Net profit | 689 | 568 | 741 | 758 |
| Net margin | 12.5% | 10.7% | 15.1% | 15.3% |
| EPS (₹) | 153.35 | 126.38 | 164.77 | 168.71 |
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Total assets | 5,699 | 5,246 | 4,597 | 4,679 |
| Total liabilities | 2,734 | 2,396 | 1,748 | 1,967 |
| Shareholders’ equity | 2,966 | 2,850 | 2,849 | 2,712 |
| Total debt | 82 | 105 | 47 | 74 |
| Cash & equivalents | 1,415 | 886 | 1,157 | 861 |
| Debt / equity | 0.03 | 0.04 | 0.02 | 0.03 |
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Operating cash flow | 1,079 | 262 | 952 | 609 |
| Capital expenditure | -65 | -43 | -46 | -77 |
| Free cash flow | 1,014 | 219 | 906 | 532 |
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Return on equity | 23.2% | 19.9% | 26.0% | 28.0% |
| Return on assets | 12.1% | 10.8% | 16.1% | 16.2% |
| Net margin | 12.5% | 10.7% | 15.1% | 15.3% |
Source: Yahoo Finance. Figures in ₹ crore unless stated.
No analyst data available for BAYERCROP. Finnhub coverage is limited for some India-listed stocks.